-
1 Comment
Shenzhen Salubris Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 11.4% below its 200 day moving average.
From a valuation standpoint, the stock is 43.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.8.
Shenzhen Salubris Pharmaceuticals Co., Ltd's total revenue sank by 33.3% to $604M since the same quarter in the previous year.
Its net income has dropped by 11759.5% to $-207M since the same quarter in the previous year.
Finally, its free cash flow fell by 78.4% to $22M since the same quarter in the previous year.
Based on the above factors, Shenzhen Salubris Pharmaceuticals Co., Ltd gets an overall score of 0/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100000FW8 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 39B |
|---|---|
| PE Ratio | 58.75 |
| Target Price | 60 |
| Beta | 0.02 |
| Dividend Yield | None |
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002294.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
